Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's Disease

Jia-Li Pu,Chong-Yao Jin,Zhong-Xuan Wang,Yi Fang,Yao-Lin Li,Nai-Jia Xue,Ran Zheng,Zhi-Hao Lin,Yi-Qun Yan,Xiao-Li Si,Ying Chen,Yi Liu,Zhe Song,Ya-Ping Yan,Jun Tian,Xin-Zhen Yin,Bao-Rong Zhang
DOI: https://doi.org/10.1002/mds.28805
IF: 9.698
2021-01-01
Movement Disorders
Abstract:ABSTRACTBackgroundEmerging evidence indicates that the apolipoprotein E (APOE) ε4 exacerbates α‐synuclein pathology.ObjectiveTo determine whether APOE ε4 contributes to motor progression in early Parkinson's disease (PD).MethodsLongitudinal data were obtained from 384 patients with PD divided into APOE ε4 carriers (n = 85) and noncarriers (n = 299) in the Parkinson's Progression Marker Initiative. Participants underwent yearly motor assessments over a mean follow‐up period of 78.9 months. Repeated measures and linear mixed models were used to test the effects of APOE ε4.ResultsThe motor progression was significantly more rapid in patients with PD carrying APOE ε4 than in noncarriers (β = 0.283, P = 0.026, 95% confidence interval: 0.033–0.532). Through subgroup analysis, we found that the effect of APOE ε4 was significant only in patients with high amyloid β burden (β = 0.761, P < 0.001, 95% confidence interval: 0.0356–1.167).Conclusions APOE ε4 may be associated with rapid motor progression in PD. © 2021 International Parkinson and Movement Disorder Society
What problem does this paper attempt to address?